Min Feng
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Hepatology top 10%
- Liver physiology and pathology
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Song Liu (1 shared paper)Wenxian Guan (1 shared paper)Wenxian Guan (2 shared papers)Feng Sun (1 shared paper)Fangcheng Zhang (2 shared papers)Hongyang Zhao (2 shared papers)Peng-Fei Yan (2 shared papers)Jun Feng (2 shared papers)
- Journals
- Journal of Surgical Oncology (1 paper)Molecular Imaging and Biology (1 paper)Materials Horizons (1 paper)Medicine (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Min Feng
30 papers receiving 827 citations
Peers
Comparison fields: 5 of 88
- Geriatrics and Gerontology 70
- Hepatology 66
- Oncology 212
- Cancer Research 112
- Immunology 153
Countries citing papers authored by Min Feng
This map shows the geographic impact of Min Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Feng more than expected).
Fields of papers citing papers by Min Feng
This network shows the impact of papers produced by Min Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Feng. The network helps show where Min Feng may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 84 | |
| 2 | 2016 | 78 | |
| 3 | 2016 | 76 | |
| 4 | 2018 | 70 | |
| 5 | 2015 | 58 | |
| 6 | 2017 | 54 | |
| 7 | 2016 | 45 | |
| 8 | 2012 | 40 | |
| 9 | 2017 | 37 | |
| 10 | 2012 | 31 | |
| 11 | 2013 | 28 | |
| 12 | 2016 | 28 | |
| 13 | 2014 | 24 | |
| 14 | 2017 | 23 | |
| 15 | 2018 | 22 | |
| 16 | Clinical significance of PD-L1 (CD274) enhanced expression in cervical squamous cell carcinoma. | 2018 | 22 |
| 17 | 2013 | 18 | |
| 18 | 2018 | 18 | |
| 19 | 2018 | 17 | |
| 20 | 2021 | 14 |
About Min Feng
Min Feng is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Surgery, having authored 31 papers that have together received 835 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Autophagy in Disease and Therapy (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Liver physiology and pathology (2 papers), interferon and immune responses (2 papers), Immune cells in cancer (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Geriatrics and Gerontology (70 citations), Hepatology (66 citations), Oncology (212 citations), Cancer Research (112 citations) and Immunology (153 citations). Min Feng has collaborated with scholars based in China and United States. Frequent co-authors include Song Liu, Wenxian Guan, Wenxian Guan, Feng Sun, Fangcheng Zhang, Hongyang Zhao, Peng-Fei Yan, Jun Feng, Jie Zhang and Jie Ding. Their work appears in journals such as Journal of Surgical Oncology, Molecular Imaging and Biology, Materials Horizons, Medicine and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.